Academia.eduAcademia.edu

Outline

Title
Abstract
Implications for Practice
Participants
Objectives
Demographic Data
Limitations
Conclusion
Study Design
Statistical Analysis
Study Population
Materials and Methods
Subjects
Data Analysis
Procedure
Methods
Results
Case Report
Discussion
References

PRHSJ V40 N1 March 2021

Profile image of Puerto Rico Health Sciences JournalPuerto Rico Health Sciences Journal

Abstract

The elimination of HIV and syphilis from Puerto Rico as per metrics of the World Health Organization has been achieved despite continued HIV risk and high background prevalence. Excellence in antenatal services and screening, deployment of antiretroviral and penicillin syphilis therapies, and proper follow-through with mothers and infants has yielded success even as control of infection overall remains elusive. We highlight the context of this achievement in our editorial to accompany the article: "

Related papers

HIV and syphilis infection in pregnant women in Ecuador: prevalence and characteristics of antenatal care
Mario J Grijalva

Sexually Transmitted Infections, 2013

Objectives This study aimed to obtain nationally representative estimates of HIV and syphilis prevalence and coverage of preventive antenatal services in pregnant women in Ecuador, in order to develop a national strategy for the elimination of mother-to-child transmission of HIV and syphilis. Methods A national probability sample of 5988 women presenting for delivery or miscarriage services was selected from 15 healthcare facilities during 2011-2012, using a two-stage cluster sample technique. Biological specimens were collected and an interview and review of medical records were performed. Agreement between these last two sources was measured. Estimates were adjusted for the sampling design. Results Estimated national HIV prevalence (0.60%) was higher than confirmed syphilis infection prevalence (0.25%). In the coastal region, HIV prevalence (1.13%) exceeded the threshold that defines a generalised epidemic and syphilis prevalence reached 0.37%. An estimated 5.9% of women did not use antenatal care services while 73.0% completed at least four consultations. HIV testing coverage (89.9%) was higher than for syphilis (71.6%). Agreement between medical records and interviews was mostly moderate (0.40-0.75). Important variables were frequently not recorded, such as timing of syphilis testing, which was not recorded in 49.6%. Conclusions The concentration of HIV and syphilis infections in the coastal region of Ecuador highlights the need for intensified prevention and a response tailored to local epidemic conditions. Major challenges for the elimination initiative include achieving universal, early access to antenatal care, improving coverage of HIV and syphilis testing, and improving the quality of medical records to support progress monitoring.

View PDFchevron_right
HIV and syphilis infection among men attending an sexually transmitted infection clinic in Puerto Rico
Geetanjoli Banerjee

Puerto Rico health sciences journal

This study aimed to assess the demographic, behavioral, and clinical factors associated with HIV and syphilis infection among a sample of men attending a sexually transmitted infection clinic during 2009 to 2010 in San Juan, Puerto Rico (PR). A sample of 350 clinical records from men visiting the clinic for the first time during 2009 to 2010 was reviewed. Descriptive statistics were used to describe the study sample, and bivariate analyses were performed separately for HIV and syphilis to identify factors associated with these infectious diseases. Variables that were significantly associated (p < 0.05) with HIV and syphilis in the bivariate analysis were considered for inclusion in the logistic regression models. Overall, 11.2% and 14.1% of the men were infected with HIV and syphilis, respectively, and 5.1% were coinfected with HIV and syphilis. In multivariate logistic regression models, ever injecting drugs (POR = 8.1; 95% CI 3.0, 21.8) and being a man who has sex with men (MSM...

View PDFchevron_right
Changes in the AIDS epidemiologic situation in Puerto Rico following health care reform and the introduction of HAART
Maria Gomez

Revista Panamericana de Salud Pública, 2005

Objectives. To compare the occurrence of AIDS as well as the sociodemographic and clinical profiles of AIDS patients in Puerto Rico before and after the introduction of highly active antiretroviral therapy (HAART) and the privatization of the island's public health care system. Methods. We compared the incident AIDS cases for two three-year periods, 1992-1994 and 1998-2000, in four populations: (1) entire United States, (2) Puerto Rico, (3) Bayamón Health Region (located in north-central Puerto Rico, it includes 11 of the island's 78 municipalities), and (4) an HIV cohort enrolled at the Universidad Central del Caribe (UCC) School of Medicine. The UCC is located in Bayamón, Puerto Rico, within an academic medical complex that houses the teaching hospital (Ramón Ruíz Arnaú University Hospital), the ambulatory health care facilities (Immunology Clinics) for patients with HIV, and administrative buildings. This represents the major government-sponsored health care infrastructure within the Bayamón Health Region. Results. Incident AIDS declined substantially between the two periods in each of the four populations studied. The 48.1% decline in Puerto Rico exceeded the 40.9% decline in the United States. The decline in Puerto Rico likely resulted from increased availability and implementation of HAART and the delivery of health care to HIV/AIDS patients in an integrated fashion within each regional ambulatory clinic. In spite of this improvement, the absolute number of patients with AIDS on the island remains high. Substantial resources for treatment and prevention are required. The proportion of new AIDS cases was lower among women, persons 40 years of age or older, the less educated, and those living alone. Injection drug use remains the predominant mode of transmission in Puerto Rico. Conclusions. Further gains in Puerto Rico's fight against AIDS will depend on the island's ability to reduce the transmission that occurs through injection drug use; the use of HAART on a larger number of vulnerable patients, particularly intravenous drug users; educational interventions to improve medication compliance in certain risk groups; and specific measures aimed at decreasing the rate of injection drug use.

View PDFchevron_right
Concerns About Hiv and Sexually Transmitted Infection Among Low-Risk and High-Risk Women ,P Uerto Rico
Georgina Silva, Carmen Zorrilla

2008

View PDFchevron_right
HIV and Syphilis Infection among Men attending a Sexually Transmitted Infection Clinic in Puerto Rico
Geetanjoli Banerjee

Puerto Rico Health Sciences Journal, 2013

Objective: This study aimed to assess the demographic, behavioral, and clinical factors associated with HIV and syphilis infection among a sample of men attending a sexually transmitted infection clinic during 2009 to 2010 in San Juan, Puerto Rico (PR).

View PDFchevron_right
HIV/AIDS prevention, care and treatment in the Region of the Americas: achievements, challenges and perspectives
Freddy Pérez

Revista panamericana de salud publica = Pan American journal of public health, 2016

View PDFchevron_right
Maternal and congenital syphilis in selected Latin America and Caribbean countries: A multi-country analysis using data from the Perinatal Information System
Monica Alonso Gonzalez

Sexual Health

Background: Maternal syphilis has an important impact on reproductive health. In 2010, World Health Organization (WHO)/Pan American Health Organization (PAHO) member countries approved the Strategy and Plan of Action for Elimination of Mother-to-Child Transmission of HIV and Congenital Syphilis in the Americas by 2015. This paper aims to describe epidemiological and programmatic characteristics related to maternal and congenital syphilis in selected countries of Latin America and Caribbean for the period 2010-12. Methods: The report is based on a multi-country, quantitative and qualitative analysis from data collected from several sources, representing a compilation of country reports from nine countries as part of the 2012 mid-term evaluation of the Strategy. Data was collected based on standardised procedures at country level. Results: Results are variable among countries. All countries have a strategic national plan to eliminate congenital syphilis, with some distinct characteristics for each country. Protocols and guidelines for the management and treatment of maternal and congenital syphilis in all countries were updated between 2011 and 2013. A high rate of missing information for all countries for some indicators was noticed. Conclusions: The main limitation of the analyses is the huge amount of missing data. Countries must continue to be supported to build capacity for collecting high-quality data on intervention coverage and inequities, and to use it as a basis for decisions about how best to reach women and children with interventions. A high level political commitment is necessary to put into practice the Regional Initiative to Eliminate Congenital Syphilis, with the support of Health Ministries.

View PDFchevron_right
Using a multisectoral approach to assess HIV/AIDS services in the western region of Puerto Rico
Gloria Asencio-Toro

… journal of public …, 2006

View PDFchevron_right
Fifteen years of HIV and syphilis outcomes among a prevention of mother-to-child transmission program in Haiti: from monotherapy to Option B
Marie Deschamps

Tropical medicine & international health : TM & IH, 2018

To evaluate mother and infant outcomes in the largest prevention of mother-to-child-transmission (PMTCT) programme in Haiti in order to identify gaps towards elimination of HIV and syphilis. Based on retrospective data from HIV+ pregnant women and their infants enrolled in PMTCT care from 1999 to 2014, we assessed maternal enrolment in PMTCT, receipt of antiretrovirals before delivery, maternal retention through delivery as well as infant enrolment in PMTCT, HIV testing and HIV infection. Four PMTCT programme periods were compared: period 1 (1999-2004, mono ARV), period 2 (2005-2009, dual ARV), period 3 (2010-2012, Option B) and period 4 (Oct 2012-2014, Option B+). Kaplan-Meier methods were used to assess retention in PMTCT care. Among 4665 pregnancies, median age was 27 years and median CD4+ was 494 cells/μl (IQR 328-691). A total of 75% of women received antiretrovirals before delivery, and 73% were retained in care through delivery. Twenty-two percent of women were lost before de...

View PDFchevron_right
362 Temas de actualidad • Current topics Sexually transmitted diseases in Latin America and the Caribbean
Antonio Gerbase

2016

Sexually transmitted diseases (STDs) have long been known for their great impact on health. In 1995, there were an estimated 333 million new cases of curable STDs among adults around the world (1). The prevalence of STDs in many developing coun-tries, including those of Latin American and the Caribbean (LAC), is extremely high. In the AIDS era there is an urgent need to adequately control and manage these diseases. A delay in diagnosing and treating STDs can lead to chronic complications and irreversible se-quelae. Women and children suffer the main conse-quences. In women, the most serious consequences are acute and chronic pelvic inflammatory diseases, infertility, ectopic pregnancy, and cervical cancer. Infection during pregnancy may cause spontaneous abortion, stillbirth, prematurity, low birthweight, congenital syphilis, and ophthalmia neonatorum (2). Controlling STDs is also important because of their relationship with HIV transmission. Several studies have shown that both ulc...

View PDFchevron_right

References (316)

  1. Zorrilla CD, Rodríguez-Figueroa L, Miranda-De León S, López-Alvarado B, Pérez E, Rabionet SE. Elimination of the Perinatal Transmission of HIV and Syphilis in Puerto Rico and Sustained Success since 2007: Con- vergence of Science, Women-Centered Care, and Policy. P R Health Sci J 2021;40:3-4.
  2. Wang AL, Qiao YP, Wang LH, et al. Integrated prevention of mother-to- child transmission for human immunodeficiency virus, syphilis and hepa- titis B virus in China. Bull World Health Organ 2015;93(1):52-6. doi: 10.2471/BLT.14.139626. PMID: 25558108; PMCID: PMC4271682.
  3. World Health Organization. WHO validates elimination of mother- to-child transmission of HIV and syphilis in Cuba. 30 June 2015 News Release: https://www.who.int/mediacentre/news/releases/2015/mtct- hiv-cuba/en/, accessed Feb. 28, 2021.
  4. U.S. Census Bureau, 2015-2019 American Community Survey 5-Year Esti- mates. Median Household Income by State: https://www.census.gov/search- results.html?searchType=web&cssp=SERP&q=median%20household%20 income, Background on the American Community Survey, see: https://www. census.gov/programs-surveys/acs/about.html and on the Puerto Rico Com- munity Survey, see: https://www.census.gov/programs-surveys/acs/about/ puerto-rico-community-survey.html, accessed February 28, 2021.
  5. Table. Pan American Health Organization (PAHO) Member States, Associate Members, Participating States, Observer States, and territories/ colonies of participating states in 2021. PAHO began as the International Sanitary Bureau in 1902 and was reorganized as the Pan American Sanitary Bureau in 1923. With the establishment of the World Health Organization (WHO), it became the WHO's Regional Office for the Americas within the United Nations system in 1949, renamed PAHO in 1958. Adapted from: https://www.paho.org/hq/index.php?option=com_cont ent&view=article&id=103:member-states&Itemid=1110&lang=en, and https://www.paho.org/en/news/2-12-2012-paho-celebrates-110th- anniversary, accessed February 28, 2021
  6. Member States Year of Admission to PAHO
  7. *Antigua and Barbuda 1982
  8. *Bahamas 1974
  9. *Barbados 1967
  10. Brazil 1929
  11. *Canada 1971
  12. *Chile 1929 10. Colombia 1933 11. Costa Rica 1926
  13. *Cuba 1925 13. *Dominica 1981 14. Dominican Republic 1929 15. Ecuador 1930 16. El Salvador 1926
  14. *Grenada 1977 18. Guatemala 1933 19. Guyana 1967 20. Haiti 1926 21. Honduras 1957 22. Jamaica 1962 23. Mexico 1929 24. Nicaragua 1925 25. Panama 1929 26. Paraguay 1939 27. Peru 1926 Member States Year of Admission to PAHO
  15. *St. Kitts and Nevis 1984 29. Saint Lucia 1980
  16. *St. Vincent and the Grenadines 1981 31. Suriname 1976 32. Trinidad and Tobago 1963
  17. *United States of America 1925 34. Uruguay 1928 35. Venezuela 1933 PRHSJ Vol. 40 No. 1 • March, 2021
  18. Vermund & Febo
  19. Zorrilla CD, Tamayo Agrait V, Febo I, et al. Reduction in the perinatal HIV transmission: the experience at the Maternal Infant Studies Center and Gamma Projects at the University of Puerto Rico School of Medicine. P R Health Sci J 2007;26(4):329-35. PMID: 18246960.
  20. Christie C, Bain B, Pierre R, et al. HIV/AIDS in women, infants, children and adolescents in Jamaica. A further "call to action". West Indian Med J 2001;50(4):258-62. PMID: 11993012.
  21. Christie CD, Steel-Duncan J, Palmer P, et al. Paediatric and perinatal HIV/AIDS in Jamaica an international leadership initiative, 2002-2007.
  22. West Indian Med J 2008;57(3):204-15. PMID: 19583118.
  23. Vermund SH, Krogstad PA. Prevention of mother-to-child HIV transmis- sion and management of paediatric HIV infection in Jamaica. West Indian Med J 2008;57(3):187-8. PMID: 19583116.
  24. Figueroa JP. The HIV epidemic in the Caribbean: meeting the challenges of achieving universal access to prevention, treatment and care. West In- dian Med J 2008;57(3):195-203. PMID: 19583117.
  25. Hintzen P, Vertovec J, Cyrus E, Padilla M, Varas-Díaz N. Introduc- tion to the special issue: Applying a Caribbean perspective to an analy- sis of HIV/AIDS. Glob Public Health 2019;14(11):1547-1556. doi: 10.1080/17441692.2019.1658122. PMID: 31537195.
  26. Verstraeten SPA, van Oers HAM, Mackenbach JP. Health Policy Per- formance in 16 Caribbean States, 2010-2015. Am J Public Health. 2019;109(4):626-632. doi: 10.2105/AJPH.2018.304733. PMID: 30789765; PMCID: PMC6417560.
  27. Mc Lean R, Theodore K, La Foucade A, et al. Austerity, and funding cuts: Implications for sustainability of the response to the Caribbean HIV/AIDS epidemic. Glob Public Health 2019;14(11):1612-1623. doi: 10.1080/17441692.2019.1657926. PMID: 31469051.
  28. Gebre Y, Forbes NM, Peters A. Review of HIV treatment progress, gaps, and challenges in the Caribbean, 2005-2015. Rev Panam Salud Publica 2016;40(6):468-473. PMID: 28718497.
  29. Hintzen PC. Precarity and the HIV/AIDS pandemic in the Ca- ribbean: Structural stigma, constitutionality, legality in develop- ment practice. Glob Public Health 2019;14(11):1624-1638. doi: 10.1080/17441692.2019.1632367. PMID: 31240999.
  30. Whitmore SK, Taylor AW, Espinoza L, Shouse RL, Lampe MA, Nesheim S. Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico. Pediatrics 2012;129(1):e74-81. doi: 10.1542/ peds.2010-3691. PMID: 22144694.
  31. Carlucci JG, Liu Y, Friedman H, et al. Attrition of HIV-exposed in- fants from early infant diagnosis services in low-and middle-income countries: a systematic review and meta-analysis. J Int AIDS Soc 2018;21(11):e25209. doi: 10.1002/jia2.25209. PMID: 30649834; PM- CID: PMC6287094.
  32. Pan American Health Organization. Elimination of mother-to-child transmission of HIV and syphilis in the Americas. Update 2016. Wash- ington, D.C. : PAHO; 2017. Accessed on February 27, 2021 from https:// iris.paho.org/bitstream/handle/10665.2/34072/9789275119556- eng.pdf 18. Office of Infectious Disease and HIV/AIDS Policy. U.S. Department of Health & Human Services. OVERVIEW Ending the HIV Epidemic. https://files.hiv.gov/s3fs-public/ending-the-hiv-epidemic-flyer.pdf, ac- cessed Feb. 28, 2021.
  33. Brady KA, Storm DS, Naghdi A, Frederick T, Fridge J, Hoyt MJ. Perinatal HIV Exposure Surveillance and Reporting in the United States, 2014. Pub- lic Health Rep 2017;132(1):76-84. doi: 10.1177/0033354916681477. PMID: 28005487; PMCID: PMC5298507.
  34. Chi BH, Mbori-Ngacha D, Essajee S, et al. Accelerating progress towards the elimination of mother-to-child transmission of HIV: a narrative re- view. J Int AIDS Soc 2020;23(8):e25571. doi: 10.1002/jia2.25571. PMID: 32820609; PMCID: PMC7440973.
  35. Carlucci JG, Liu Y, Clouse K, Vermund SH. Attrition of HIV-positive children from HIV services in low and middle-income countries. AIDS 2019;33(15):2375-2386. doi: 10.1097/QAD.0000000000002366. PMID: 31764102; PMCID: PMC6905128.
  36. Brooks KM, Momper JD, Pinilla M, et al. Pharmacokinetics of tenofo- vir alafenamide with and without cobicistat in pregnant and postpar- tum women living with HIV. AIDS 2021;35(3):407-417. doi: 10.1097/ QAD.0000000000002767. PMID: 33252495.
  37. Melendez-Guerrero LM, Arroyo MA, Vega ME, Jimenez E, Hillyer GV, Cadilla CL. Characterization of HIV isolates from Puerto Rican mater- nal-infant pairs reveal predominance of non-syncytium inducing (NSI) variants with CCR5 genotype. Cell Mol Biol (Noisy-le-grand) 2001;47 Online Pub:OL39-47. PMID: 11936872.
  38. Tuomala RE, Kalish LA, Zorilla C, et al. Changes in total, CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in hu- man immunodeficiency virus-infected women. The Women and Infants Transmission Study. Obstet Gynecol 1997;89(6):967-74. doi: 10.1016/ s0029-7844(97)00129-4. PMID: 9170476.
  39. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and pre- vention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002;29(5):484-94. doi: 10.1097/00126334-200204150-00009. PMID: 11981365.
  40. Demeke HB, Luo Q, Luna-Gierke RE, et al. HIV Care Outcomes among Hispanics/Latinos with Diagnosed HIV in the United States by Place of Birth-2015-2018, Medical Monitoring Project. Int J Environ Res Public Health 2019;17(1):171. doi: 10.3390/ijerph17010171. PMID: 31881732; PMCID: PMC6981500.
  41. Zorrilla CD. HIV infection in women: perinatal issues and cervical cancer surveillance. Top HIV Med 2007;15(1):1-5. PMID: 17406077.
  42. Kates J, Dawson L, Horn TH, et al. Insurance coverage and financing landscape for HIV treatment and prevention in the USA. Lancet. 2021 Feb 18:S0140-6736(21)00397-4. doi: 10.1016/S0140-6736(21)00397-
  43. Epub ahead of print. PMID: 33617778.
  44. Valentín DC, Candelario N, Carrasquillo OY, Figueroa L, Sánchez JL. Leprosy in Puerto Rico: insight into the new millennia. Int J Dermatol 2017;56(4):440-443. doi: 10.1111/ijd.13496. PMID: 28233305.
  45. Hewitt R, Willingham AL. Status of Schistosomiasis Elimination in the Caribbean Region. Trop Med Infect Dis 2019;4(1):24. doi: 10.3390/ tropicalmed4010024. PMID: 30708966; PMCID: PMC6473873.
  46. Kortsmit K, Salvesen von Essen B, Warner L, et al. Preventing Vector- Borne Transmission of Zika Virus Infection During Pregnancy, Puerto Rico, USA, 2016-2017. Emerg Infect Dis 2020;26(11):2717-2720. doi: 10.3201/eid2611.201614. PMID: 33079044; PMCID: PMC7588518.
  47. Matysiak A, Roess A. Interrelationship between Climatic, Ecologic, Social, and Cultural Determinants Affecting Dengue Emergence and Transmission in Puerto Rico and Their Implications for Zika Response. J Trop Med 2017;2017:8947067. doi: 10.1155/2017/8947067. PMID: 28717366; PMCID: PMC5498925.
  48. Noyd DH, Sharp TM. Recent Advances in Dengue: Relevance to Puerto Rico. P R Health Sci J 2015;34(2):65-70. PMID: 26061055; PMCID: PMC4587385.
  49. Aboukheir MK, Alvarado-Ramy F, Fernandez Vazquez M, Joglar O. Notes from the Field: Tuberculosis Control in the Aftermath of Hurricane Maria -Puerto Rico, 2017. MMWR Morb Mortal Wkly Rep 2019 Jan 18;68(2):46-47. doi: 10.15585/mmwr.mm6802a6. PMID: 30653488.
  50. Zorrilla CD. The View from Puerto Rico -Hurricane Maria and Its Aftermath. N Engl J Med 2017;377(19):1801-1803. doi: 10.1056/ NEJMp1713196. PMID: 29019710.
  51. Vega Ocasio D, Pérez Ramos JG, Dye TDV. Conducting an immersive community-based assessment of post-hurricane experience among Puer- to Ricans: lived experience of medical ecology in an environmental disas- ter and migration. BMC Public Health 2020;20(1):1628. doi: 10.1186/ s12889-020-09735-w. PMID: 33121460; PMCID: PMC7596926.
  52. Welton M, Vélez Vega CM, Murphy CB, et al. Impact of Hurricanes Irma and Maria on Puerto Rico Maternal and Child Health Research Programs. Matern Child Health J 2020;24(1):22-29. doi: 10.1007/s10995-019- 02824-2. PMID: 31728717; PMCID: PMC7059554.
  53. Rios C, Ling E, Rivera Gutierrez R, et al. Puerto Rico Health System Resil- ience After Hurricane Maria: Implications for Disaster Preparedness in the COVID-19 Era. medRxiv [Preprint] 2020 Sep 23:2020.09.20.20198531. doi: 10.1101/2020.09.20.20198531. PMID: 32995821; PMCID: PMC7523162.
  54. Langston B, Armes J, Levy A, Tidey E, Ream E. The prevalence and se- verity of fatigue in men with prostate cancer: a systematic review of the literature. Support Care Cancer. 2013;21(6):1761-1771. doi:10.1007/ s00520-013-1751-5
  55. O'Gorman C, Denieffe S, Gooney M. Literature review: preoperative radiotherapy and rectal cancer -impact on acute symptom presentation and quality of life. J Clin Nurs. 2014;23(3-4):333-351. doi:10.1111/ jocn.12138
  56. Yoon J, Malin JL, Tisnado DM, et al. Symptom management after breast cancer treatment: is it influenced by patient characteristics?. Breast Can- cer Res Treat. 2008;108(1):69-77. doi:10.1007/s10549-007-9580-1
  57. Gonzalez VJ, McMillan S, Pedro E, Tirado-Gomez M, Saligan LN. The Health related Quality of Life of Puerto Ricans during Cancer Treat- ments; A Pilot Study. P R Health Sci J. 2018;37(1):46-51.
  58. Jakobsson S, Ahlberg K, Taft C, Ekman T. Exploring a link between fatigue and intestinal injury during pelvic radiotherapy. Oncologist. 2010;15(9):1009-1015. doi:10.1634/theoncologist.2010-0097.
  59. Jordan KR, Loman BR, Bailey MT, Pyter LM. Gut microbiota-immune- brain interactions in chemotherapy-associated behavioral comorbidities. Cancer. 2018;124(20):3990-3999. doi:10.1002/cncr.31584
  60. Ferreira MR, Muls A, Dearnaley DP, Andreyev HJ. Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel dis- ease for the radiation oncologist. Lancet Oncol. 2014;15(3):e139-e147. doi:10.1016/S1470-2045(13)70504-7
  61. Kiecolt-Glaser JK, Derry HM, Fagundes CP. Inflammation: de- pression fans the flames and feasts on the heat. Am J Psychiatry. 2015;172(11):1075-1091. doi:10.1176/appi.ajp.2015.15020152
  62. Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, Hyland NP. Break- ing down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015;9:392. Published 2015 Oct 14. doi:10.3389/fncel.2015.00392
  63. Nejdfors P, Ekelund M, Weström BR, Willén R, Jeppsson B. Intestinal permeability in humans is increased after radiation therapy. Dis Colon Rectum. 2000;43(11):1582-1588. doi:10.1007/BF02236743
  64. Touchefeu Y, Montassier E, Nieman K, et al. Systematic review: the role of the gut microbiota in chemotherapy-or radiation-induced gastrointes- tinal mucositis -current evidence and potential clinical applications. Ali- ment Pharmacol Ther. 2014;40(5):409-421. doi:10.1111/apt.12878
  65. Derikx JP, Blijlevens NM, Donnelly JP, et al. Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic stem-cell transplant recipients. Ann Oncol. 2009;20(2):337-342. doi:10.1093/annonc/mdn579
  66. Kelly JR, Kennedy PJ, Cryan JF, Dinan TG, Clarke G, & Hyland NP. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Frontiers in cellular neuroscience. 2015;9, 392. ttps://doi.org/10.3389/fncel.2015.00392
  67. Wang A, Ling Z, Yang Z, et al. Gut microbial dysbiosis may predict di- arrhea and fatigue in patients undergoing pelvic cancer radiotherapy: a pilot study. PLoS One. 2015;10(5):e0126312. Published 2015 May 8. doi:10.1371/journal.pone.0126312
  68. Giloteaux L, Goodrich JK, Walters WA, Levine SM, Ley RE, Hanson MR. Reduced diversity and altered composition of the gut microbiome in in- dividuals with myalgic encephalomyelitis/chronic fatigue syndrome. Mi- crobiome. 2016;4(1):30. Published 2016 Jun 23. doi:10.1186/s40168- 016-0171-4
  69. Tlaskalová-Hogenová H, Stepánková R, Hudcovic T, et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflamma- tory and autoimmune diseases. Immunol Lett. 2004;93(2-3):97-108. doi:10.1016/j.imlet.2004.02.005
  70. Maes M, Twisk FN, Kubera M, Ringel K, Leunis JC, Geffard M. In- creased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome. J Affect Disord. 2012;136(3):909-917. doi:10.1016/j. jad.2011.09.010
  71. Qin L, Wu X, Block ML, et al. Systemic LPS causes chronic neuroinflam- mation and progressive neurodegeneration. Glia. 2007;55(5):453-462. doi:10.1002/glia.20467
  72. Zhang ZT, Du XM, Ma XJ, et al. Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome. J Neuroinflammation. 2016;13(1):71. Published 2016 Apr 5. doi:10.1186/s12974-016-0539-1
  73. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7(7):688-693. doi:10.1038/sj.embor.7400731
  74. Rinninella E, Raoul P, Cintoni M, et al. What is the Healthy Gut Micro- biota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms. 2019;7(1):14. Published 2019 Jan 10. doi:10.3390/microorganisms7010014
  75. Bajic JE, Johnston IN, Howarth GS, Hutchinson MR. From the Bot- tom-Up: Chemotherapy and Gut-Brain Axis Dysregulation. Front Be- hav Neurosci. 2018;12:104. Published 2018 May 22. doi:10.3389/fn- beh.2018.00104
  76. Manichanh C, Varela E, Martinez C, et al. The gut microbiota pre- dispose to the pathophysiology of acute postradiotherapy diarrhea. Am J Gastroenterol. 2008;103(7):1754-1761. doi:10.1111/j.1572- 0241.2008.01868.x
  77. Nam YD, Kim HJ, Seo JG, Kang SW, Bae JW. Impact of pelvic radiothera- py on gut microbiota of gynecological cancer patients revealed by massive PRHSJ Vol. 40 No. 1 • March, 2021
  78. Marrero et al pyrosequencing. PLoS One. 2013;8(12):e82659. Published 2013 Dec 18. doi:10.1371/journal.pone.0082659
  79. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104(34):13780-13785. doi:10.1073/pnas.0706625104
  80. Marietta EV, Murray JA, Luckey DH, et al. Suppression of Inflammatory Arthritis by Human Gut-Derived Prevotella histicola in Humanized Mice. Arthritis Rheumatol. 2016;68(12):2878-2888. doi:10.1002/art.39785
  81. Peng BJ, Cao CY, Li W, et al. Diagnostic Performance of Intestinal Fuso- bacterium nucleatum in Colorectal Cancer: A Meta-Analysis. Chin Med J (Engl). 2018;131(11):1349-1356. doi:10.4103/0366-6999.232814
  82. Iliev ID, Leonardi I. Fungal dysbiosis: immunity and interactions at mu- cosal barriers. Nat Rev Immunol. 2017;17(10):635-646. doi:10.1038/ nri.2017.55
  83. Mandarano AH, Giloteaux L, Keller BA, Levine SM, Hanson MR. Eukary- otes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome. PeerJ. 2018;6:e4282. Published 2018 Jan 22. doi:10.7717/ peerj.4282
  84. Kume S, Yamato M, Tamura Y, et al. Potential biomarkers of fa- tigue identified by plasma metabolome analysis in rats. PLoS One. 2015;10(3):e0120106. Published 2015 Mar 20. doi:10.1371/journal. pone.0120106
  85. Lyon DE, Starkweather A, Yao Y, et al. Pilot Study of Metabolomics and Psychoneurological Symptoms in Women With Early Stage Breast Cancer. Biol Res Nurs. 2018;20(2):227-236. doi:10.1177/1099800417747411
  86. Galland L. The gut microbiome and the brain. J Med Food. 2014;17(12):1261-1272. doi:10.1089/jmf.2014.7000
  87. Sheedy JR, Wettenhall RE, Scanlon D, et al. Increased d-lactic Acid in- testinal bacteria in patients with chronic fatigue syndrome. In Vivo. 2009;23(4):621-628.
  88. Hurwitz MD, Kaur P, Nagaraja GM, Bausero MA, Manola J, Asea A. Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. Radiother Oncol. 2010;95(3):350-358. doi:10.1016/j. radonc.2010.03.024
  89. Rich T, Zhao F, Cruciani RA, Cella D, Manola J, Fisch MJ. Association of fatigue and depression with circulating levels of proinflammatory cyto- kines and epidermal growth factor receptor ligands: a correlative study of a placebo-controlled fatigue trial. Cancer Manag Res. 2017;9:1-10. Pub- lished 2017 Jan 31. doi:10.2147/CMAR.S115835
  90. Abt MC, Osborne LC, Monticelli LA, et al. Commensal bacteria cali- brate the activation threshold of innate antiviral immunity. Immunity. 2012;37(1):158-170. doi:10.1016/j.immuni.2012.04.011
  91. Khokhlova EV, Smeianov VV, Efimov BA, Kafarskaia LI, Pavlova SI, Shko- porov AN. Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants. Microbiol Immunol. 2012;56(1):27- 39. doi:10.1111/j.1348-0421.2011.00398.x
  92. Matsumoto M, Benno Y. The relationship between microbiota and poly- amine concentration in the human intestine: a pilot study. Microbiol Im- munol. 2007;51(1):25-35. doi:10.1111/j.1348-0421.2007.tb03887.x
  93. Lin XB, Dieleman LA, Ketabi A, et al. Irinotecan (CPT-11) chemo- therapy alters intestinal microbiota in tumour bearing rats. PLoS One. 2012;7(7):e39764. doi:10.1371/journal.pone.0039764
  94. Minton O, Stone P, Richardson A, Sharpe M, Hotopf M. Drug therapy for the management of cancer related fatigue. Cochrane Database Syst Rev. 2008;(1):CD006704. Published 2008 Jan 23. doi:10.1002/14651858. CD006704.pub2
  95. Mustian KM, Alfano CM, Heckler C, et al. Comparison of Pharmaceuti- cal, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis. JAMA Oncol. 2017;3(7):961-968. doi:10.1001/jamaon- col.2016.6914
  96. Lee JY, Chu SH, Jeon JY, et al. Effects of 12 weeks of probiotic supple- mentation on quality of life in colorectal cancer survivors: a double-blind, randomized, placebo-controlled trial. Dig Liver Dis. 2014;46(12):1126- 1132. doi:10.1016/j.dld.2014.09.004
  97. Paulsen JA, Ptacek TS, Carter SJ, et al. Gut microbiota composition associated with alterations in cardiorespiratory fitness and psychoso- cial outcomes among breast cancer survivors. Support Care Cancer. 2017;25(5):1563-1570. doi:10.1007/s00520-016-3568-5
  98. Sitkin S, Pokrotnieks J. Clinical Potential of Anti-inflammatory Effects of Faecalibacterium prausnitzii and Butyrate in Inflammatory Bowel Dis- ease. Inflamm Bowel Dis. 2019;25(4):e40-e41. doi:10.1093/ibd/izy258
  99. Zick SM, Colacino J, Cornellier M, Khabir T, Surnow K, Djuric Z. Fatigue reduction diet in breast cancer survivors: a pilot randomized clinical trial. Breast Cancer Res Treat. 2017;161(2):299-310. doi:10.1007/s10549- 016-4070-y
  100. George SM, Alfano CM, Neuhouser ML, et al. Better postdiagnosis diet quality is associated with less cancer-related fatigue in breast cancer sur- vivors. J Cancer Surviv. 2014;8(4):680-687. doi:10.1007/s11764-014- 0381-3
  101. Pettersson A, Johansson B, Persson C, Berglund A, Turesson I. Effects of a dietary intervention on acute gastrointestinal side effects and other aspects of health-related quality of life: a randomized controlled trial in prostate cancer patients undergoing radiotherapy. Radiother Oncol. 2012;103(3):333-340. doi:10.1016/j.radonc.2012.04.006
  102. González-Mercado VJ, Pérez-Santiago J, Lyon D, et al. The Role of Gut Microbiome Perturbation in Fatigue Induced by Repeated Stress from Chemoradiotherapy: A Proof of Concept Study. Adv Med. 2020;2020:6375876. Published 2020 Feb 7. doi:10.1155/2020/6375876
  103. González-Mercado VJ, Sarkar A, Penedo FJ, et al. Gut microbiota per- turbation is associated with acute sleep disturbance among rectal cancer patients. J Sleep Res. 2020;29(3):e12915. doi:10.1111/jsr.12915
  104. González-Mercado VJ, Henderson WA, Sarkar A, et al. Changes in Gut Microbiome Associated With Co-Occurring Symptoms Develop- ment During Chemo-Radiation for Rectal Cancer: A Proof of Concept Study [published online ahead of print, 2020 Jul 23]. Biol Res Nurs. 2020;1099800420942830. doi:10.1177/1099800420942830
  105. Alves LF, Westmann CA, Lovate GL, de Siqueira GMV, Borelli TC, Guaz- zaroni ME. Metagenomic Approaches for Understanding New Concepts in Microbial Science. Int J Genomics. 2018;2018:2312987. Published 2018 Aug 23. doi:10.1155/2018/2312987
  106. Shibata N, Kunisawa J, Kiyono H. Dietary and Microbial Metabolites in the Regulation of Host Immunity. Front Microbiol. 2017;8:2171. Pub- lished 2017 Nov 7. doi:10.3389/fmicb.2017.02171
  107. Deng X, Li Z, Li G, Li B, Jin X, Lyu G. Comparison of Microbiota in Pa- tients Treated by Surgery or Chemotherapy by 16S rRNA Sequencing Re- veals Potential Biomarkers for Colorectal Cancer Therapy. Front Microbi- ol. 2018;9:1607. Published 2018 Jul 17. doi:10.3389/fmicb.2018.01607
  108. Wardill HR, Tissing WJE. Determining risk of severe gastrointestinal tox- icity based on pretreatment gut microbial community in patients receiving cancer treatment: a new predictive strategy in the quest for personalized cancer medicine. Curr Opin Support Palliat Care. 2017;11(2):125-132. doi:10.1097/SPC.0000000000000265
  109. World Health Organization. Global Health Observatory (GHO) data [WHO Web site]. 2019. Available at: https://www.who.int/gho/hiv/ en/. Accessed January 9, 2020.
  110. WebMD. Children with HIV and AIDS. [WebMD Web site]. January 9, 2020. Available at: https://www.webmd.com/hiv-aids/guide/hiv-in- children#1; Accessed January 9, 2020.
  111. AIDS Info. Epidemics transition metrics. [UNAIDS Web site]. Available at: http://aidsinfo.unaids.org/ . Accessed February 21, 2019.
  112. Nesheim SR, FitzHarris LF, Lampe MA, Gray KM. Reconsidering the number of women with HIV infection who give birth annually in the United States. Public Health Rep. 2018; 133:637-643.
  113. Nesheim SR, Wiener J, Fitz Harris LF, Lampe MA, Weidle PJ. Brief report: estimated incidence of perinatally acquired HIV infection in the United States, 1978-2013. J Acquir Immune Defic Syndr. 2017;76:461-464.
  114. Peters H, Francis K, Sconza R, Peckham C, Tookey PA, Thorne C. UK mother-to-child HIV transmission rates continue to decline: 2012-2014. Clin Infect Dis. 2017; 64:527-528.
  115. Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, et al. Rapid ART Initiation Reduces Loss Between HIV Testing and Treatment: The RapIT Trial. 2015. Poster session presented at the Conference of Retroviruses and Opportunistic Infections, Seattle, Washington. Available at: http://www.croiconference.org/sessions/rapid- art-initiation-reduces-loss-between-hiv-testing-and-treatment-rapit-trial. Accessed February 21, 2019.
  116. Highleyman L. RAPID Program Leads to Faster HIV Suppression [BETA Web site]. July 24, 2015. Available at: https://betablog.org/rapid-pro- gram-leads-to-faster-hiv-suppression/. Accessed February 21, 2019.
  117. World Health Organization. Criteria and processes for validation: Elimi- nation of Mother-to-Child transmission of HIV and Syphilis [WHO Web site]. 2014. Available at: https://apps.who.int/iris/bitstream/han- dle/10665/112858/ 9789241505888_eng.pdf?sequence=1. Accessed February 21, 2019.
  118. World Health Organization. WHO validates elimination of mother- to-child-transmission of HIV and syphilis in Cuba. [WHO Web site].
  119. World Health Organization. Global guidance on criteria and processes for validation: Elimination of Mother-to-Child transmission of HIV and Syphilis [WHO Web site]. 2017. Available at: https://www.who.int/re- productivehealth/ publications/emtct-hiv-syphilis/en/. Accessed Febru- ary 21, 2019.
  120. Zorrilla C, Tamayo Agrait V, Febo I, Santiago L, Díaz C, Salabarria I, et al. Reduction in the Perinatal HIV transmission at the Maternal Infant Studies Center and Gamma Projects at the UPR School of Medicine. P R Health Sci J. 2007: 26:329-335.
  121. Entrevista al Dr. Raúl Castellanos: Son importantes la continuidad y la visión integral que puede dar el médico de familia. Galenus. Año 11; 68:52-55.
  122. Pan American Health Organization. Member States [PAHO Web site]. Available at: Url: https://www.paho.org/hq/index.php?option=com_ content&view =article&id=103: member-states&Itemid=1110&lang=en.
  123. Accessed February 21, 2019.
  124. National Institute of Allergy and Infectious Disease. ACTG 076 Ques- tions and Answers. [AIDS Info Web site]. February 20, 1994. Available at: https://aidsinfo.nih.gov/news/101/actg-076-questions-and-answers.
  125. Accessed February 21, 2019.
  126. Health Resource & Services Administration. About the Ryan White HIV/AIDS Program. [HRSA Web site]. February 2019. Available at: https://hab.hrsa.gov/about-ryan-white-hivaids-program/about-ryan- white-hivaids-program. Accessed February 21, 2019.
  127. Puerto Rico HIV/AIDS Surveillance Summary. Cumulative HIV/AIDS Cases Diagnosed as of January 31, 2019. January 2019.
  128. Gomez MA, Fernandez DM, Otero JF, Miranda S, Hunter R. The shape of the HIV/AIDS epidemic in Puerto Rico. Rev Panam Salud Pública. 2000; 7:377-383.
  129. CDC. Prenatal HIV testing. Morb Mortal Wkly Rep. November 9, 2001; 50:1-58.
  130. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency vi- rus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-1180.
  131. CDC. US Public Health Service recommendations for human immuno- deficiency virus counseling and voluntary testing for pregnant women. Morb Mortal Wkly Rep. July 7, 1995; 44:1-14.
  132. CDC. Zidovudine for the Prevention of HIV Transmission from Mother to Infant. Morb Mortal Wkly Rep. April 24, 1994; 43:285-287.
  133. Available at: http://www.salud.gov.pr/Profesio- nales-y-Proveedores/Protocolos/Orden%20Adminitrativa%20Num%20 307%20-2%20%20Pruebas%20de%20VIH%20Prenatales.pdf. Accessed February 21, 2019.
  134. Alomar M, Alenazi F, Alruwaili N. Accuracy of acetaminophen dosing in children by caregivers in Saudi Arabia. Ann Saudi Med. 2011;31(5):513- 517. doi:10.4103/0256-4947.84630
  135. Shapiro DJ, Fine AM. Patient Ethnicity and Pediatric Visits to the Emer- gency Department for Fever [published online ahead of print, 2019
  136. Pediatr Emerg Care. 2019;10.1097/PEC.0000000000001945. doi:10.1097/PEC.0000000000001945
  137. Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Medication use among children <12 years of age in the United States: results from the Slone Sur- vey. Pediatrics. 2009;124(2):446-454. doi:10.1542/peds.2008-2869
  138. Lexicomp. Wolters Kluwer. 2020. Accessed Month 12, 2020. http://on- line.lexi.com
  139. Centers for Disease Control and Prevention (CDC). Nonfatal, uninten- tional medication exposures among young children--United States, 2001- 2003. MMWR Morb Mortal Wkly Rep. 2006;55(1):1-5.
  140. Li SF, Lacher B, Crain EF. Acetaminophen and ibuprofen dosing by par- ents. Pediatr Emerg Care. 2000;16(6):394-397. doi:10.1097/00006565- 200012000-00003
  141. Anderson C, Rolfe P, Brennan-Hunter A. Administration of over-the- counter medication to children at home--a survey of parents from com- munity health centers. J Community Health Nurs. 2013;30(3):143-154. doi:10.1080/07370016.2013.806716
  142. Emmerton L, Chaw XY, Kelly F, et al. Management of children's fever by parents and caregivers: Practical measurement of func- tional health literacy. J Child Health Care. 2014;18(4):302-313. doi:10.1177/1367493513496663
  143. The Acetaminophen Awareness Coalition. 2020. KnowYourDose.org. Accessed November 13, 2020. https://www.knowyourdose.org/the- acetaminophen-awareness-coalition/
  144. Catlin JR, Brass EP. The Effectiveness of Nonprescription Drug Labels in the United States: Insights from Recent Research and Opportunities for the Future. Pharmacy (Basel). 2018;6(4):119. Published 2018 Oct 26. doi:10.3390/pharmacy6040119
  145. Yin HS, Mendelsohn AL, Fierman A, van Schaick L, Bazan IS, Dreyer BP. Use of a pictographic diagram to decrease parent dosing errors with infant acetaminophen: a health literacy perspective. Acad Pediatr. 2011;11(1):50-57. doi:10.1016/j.acap.2010.12.007
  146. Harris LM, Dreyer BP, Mendelsohn AL, et al. Liquid Medication Dosing Errors by Hispanic Parents: Role of Health Literacy and English Proficien- cy. Acad Pediatr. 2017;17(4):403-410. doi:10.1016/j.acap.2016.10.001
  147. Bilenko N, Tessler H, Okbe R, Press J, Gorodischer R. Determinants of antipyretic misuse in children up to 5 years of age: a cross-sectional study. Clin Ther. 2006;28(5):783-793. doi:10.1016/j.clinthera.2006.05.010
  148. Goldman RD, Scolnik D. Underdosing of acetaminophen by parents and emergency department utilization. Pediatr Emerg Care. 2004;20(2):89- 93. doi:10.1097/01.pec.0000113877.10140.d2
  149. Shah R, Blustein L, Kuffner E, Davis L. Communicating doses of pediatric liquid medicines to parents/caregivers: a comparison of written dosing directions on prescriptions with labels applied by dispensed pharmacy. J Pediatr. 2014;164(3):596-601.e1. doi:10.1016/j.jpeds.2013.11.007
  150. Puerto Rico Health Department. Puerto Rico HIV/AIDS Surveillance Summary: Cumulative HIV/AIDS Cases Diagnosed as of July 31, 2020.
  151. San Juan: HIV/AIDS Surveillance Program, Office of Epidemiology and Research; 2020.
  152. Centers for Disease Control and Prevention. Diagnoses of HIV Infec- tion in the United States and Dependent Areas, 2018 (Updated). Vol 31. Atlanta, GA: Centers for Disease Control and Prevention; 2018. http://
  153. Herbenick D, Reece M, Schick V, Sanders SA, Dodge B, Fortenberry JD. Sexual behavior in the United States: Results from a national probabil- ity sample of men and women ages 14-94. J Sex Med. 2010;7:255-265. doi:10.1111/j.1743-6109.2010.02012.x
  154. Reece M, Herbenick D, Schick V, Sanders SA, Dodge B, Fortenberry JD. Condom use rates in a national probability sample of males and fe- males ages 14 to 94 in the United States. J Sex Med. 2010;7:266-276. doi:10.1111/j.1743-6109.2010.02017.x
  155. O'Leary A, DiNenno E, Honeycutt A, et al. Contribution of anal sex to HIV prevalence among heterosexuals: A modeling analysis. AIDS Behav. 2017;21:2895-2903. doi:10.1007/s10461-016-1635-z
  156. Herbenick D, Schick V, Reece M. Characteristics of condom and lubri- cant use among a nationally representative probability sample of adults ages 18-59 in the United States. J Sex Med. 2013;10:474-483.
  157. PRHSJ Vol. 40 No. 1 • March, 2021
  158. Pérez-Jiménez et al
  159. Herbst JH, Kay LS, Passin WF, Lyles CM, Crepaz N, Marin B V. A system- atic review and meta-analysis of behavioral interventions to reduce HIV risk behaviors of Hispanics in the United States and Puerto Rico. AIDS Behav. 2007;11:25-47.
  160. Rodriguez-Diaz CE, Collazo E, Dodge B, et al. "Sexplorando": Sexual practices and condom use among an internet-based sample of men and women in Puerto Rico. J Sex Med. 2014;11:2385-2395.
  161. Noar SM, Webb E, Van Stee S, et al. Sexual partnerships, risk behaviors, and condom use among low-income heterosexual African Americans: A qualitative study. Arch Sex Behav. 2012;41:959-970. doi:10.1007/ s10508-011-9890-6
  162. VanDevanter N, Duncan A, Burrell-Piggott T, et al. The influence of sub- stance use, social sexual environment, psychosocial factors, and partner characteristics on high-risk sexual behavior among young Black and La- tino men who have sex with men living with HIV: A qualitative study. AIDS Patient Care STDS. 2011;25:113-121. doi:10.1089/apc.2010.0100
  163. Noar SM, Zimmerman RS, Atwood KA. Safer sex and sexually transmit- ted infections from a relationship perspective. In: Harvey JH, Wenzel A, Sprecher S, eds. The Handbook of Sexuality in Close Relationships. Mah- wah, NJ: Lawrence Erlbaum Associates Publishers; 2004:519-544.
  164. Rosengard C, Adler NE, Gurvey JE, Ellen JM. Adolescent partner-type experience: Psychosocial and behavioral differences. Perspect Sex Reprod Health. 2005;37:141-147. doi:10.1363/psrh.37.141.05
  165. Lei JH, Liu LR, Wei Q, et al. Circumcision status and risk of HIV acquisi- tion during heterosexual intercourse for both males and females: A meta- analysis. Tang JW, ed. PLoS One. 2015;10:e0125436. doi:10.1371/jour- nal.pone.0125436
  166. Sabogal F, Catania JA. HIV risk factors, condom use, and HIV an- tibody testing among heterosexual Hispanics: The National AIDS Behavioral Surveys (NABS). Hisp J Behav Sci. 1996;18:367-391. doi:10.1177/07399863960183007
  167. Were E, Curran K, Delany-Moretlwe S, et al. A prospective study of frequency and correlates of intimate partner violence among African heterosexual HIV serodiscordant couples. AIDS. 2011;25:2009-2018. doi:10.1097/QAD.0b013e32834b005d
  168. Malunguza NJ, Hove-Musekwa SD, Musuka G, Mukandavire Z. Investi- gating alcohol consumption as a risk factor for HIV transmission in het- erosexual settings in sub-Saharan African communities. Bull Math Biol. 2012;74:2094-2124. doi:10.1007/s11538-012-9747-8
  169. Bowleg L, Raj A. Shared communities, structural contexts, and HIV risk: Prioritizing the HIV risk and prevention needs of black hetero- sexual men. Am J Public Health. 2012;102:S173-S177. doi:10.2105/ AJPH.2011.300342
  170. Bowen AM, Horvath K, Williams ML. A randomized control trial of In- ternet-delivered HIV prevention targeting rural MSM. Health Educ Res. 2007;22:120-127. doi:10.1093/her/cyl057
  171. Statista. Percentage of population using the internet in Puerto Rico be- tween 2010 and 2017. https://www.statista.com/statistics/1055505/ internet-penetration-puerto-rico/. Published 2020. Accessed August 24, 2020.
  172. Pérez-Jiménez D, Seal DW, Ronis DL. A pilot intervention to promote safer sex in heterosexual Puerto Rican couples. Couple Fam Psychol Res Pract. 2014;3:193-206. doi:10.1037/cfp0000022
  173. Pérez-Jiménez D, Varas-Díaz N, Serrano-García I, Cintrón-Bou FN, Cabrera-Aponte M del C. Instrumento de Información, Motivación y Conductas-Español (IIMC-E). 2004.
  174. R Core Team. R: A language and environment for statistical computing. R foundation for statistical computing. 2019. https://www.r-project.org/.
  175. Hayes A. Introduction to Mediation, Moderation, and Conditional Pro- cess Analysis: A Regression-Based Approach. Guildford Press; 2018.
  176. Rosseel Y. lavaan: An R Package for Structural Equation Modeling. J Stat Softw. 2012;48:1-36.
  177. Hair J, Black W, Babin B, Anderson R. Multivariate Data Analysis. 7th ed. Pearson Education Limited; 2014.
  178. Hock-Long L, Henry-Moss D, Carter M, et al. Condom use with se- rious and casual heterosexual partners: Findings from a community venue-based survey of young adults. AIDS Behav. 2013;17:900-913. doi:10.1007/s10461-012-0177-2
  179. Prati G, Mazzoni D, Zani B. Perceived behavioural control, subjective norms, attitudes and intention to use condom: A longitudinal cross- lagged design. Psychol Health. 2014;29:1119-1136. doi:10.1080/08870 446.2014.913043
  180. Teva I, Bermúdez MP, Ramiro MT. Satisfacción sexual y actitudes hacia el uso del preservativo en adolescentes: Evaluacion y análisis de su relación con el uso del preservativo. Rev Latinoam Psicol. 2014;46:127-136.
  181. Pettifor A, Macphail C, Anderson AD, Maman S. "If I buy the Kellogg's then he should [buy] the milk": Young women's perspectives on relation- ship dynamics, gender power and HIV risk in Johannesburg, South Af- rica. Cult Health Sex. 2012;14:477-490. doi:10.1080/13691058.2012.66 7575
  182. Saleem HT, Surkan PJ, Kerrigan D, Kennedy CE. Application of an eco- logical framework to examine barriers to the adoption of safer conception strategies by HIV-affected couples. AIDS Care. 2016;28:197-204. doi:10. 1080/09540121.2015.1074652
  183. Ulibarri MD, Strathdee SA, Lozada R, et al. Intimate partner violence among female sex workers in two Mexico-U.S. border cities: Partner char- acteristics and HIV risk-behaviors as correlates of abuse. Psychol Trauma Theory, Res Pract Policy. 2010;2:318-325. doi:10.1037/a0017500
  184. Alexander KA, Coleman CL, Deatrick JA, Jemmott LS. Moving beyond safe sex to women-controlled safe sex: A concept analysis. J Adv Nurs. 2012;68:1858-1869. doi:10.1111/j.1365-2648.2011.05881.x
  185. Schuyler AC, Masvawure TB, Smit JA, et al. Building young women's knowledge and skills in female condom use: Lessons learned from a South African intervention. Health Educ Res. 2016;31:260-272. doi:10.1093/ her/cyw001
  186. Kretsch N, Harden KP. Marriage, divorce, and alcohol use in young adulthood: A longitudinal sibling-comparison study. Emerg Adulthood. 2014;2:138-149. doi:http://dx.doi.org/10.1177/2167696813513260
  187. Miller-Tutzauer C, Leonard KE, Windle M. Marriage and alcohol use: A longitudinal study of "maturing out". J Stud Alcohol. 1991;52:434-440.
  188. Davis KC, Masters NT, Eakins D, et al. Alcohol intoxication and condom use self-efficacy effects on women's condom use intentions. Addict Behav. 2014;39:153-158. doi:10.1016/j.addbeh.2013.09.019
  189. Walsh JL, Fielder RL, Carey KB, Carey MP. Do alcohol and marijuana use decrease the probability of condom use for college women? J Sex Res. 2014;51:145-158. doi:10.1080/00224499.2013.821442
  190. Nirumand MC, Hajialyani M, Rahimi R, et al. Dietary Plants for the Prevention and Management of Kidney Stones: Preclinical and Clinical Evidence and Molecular Mechanisms. Int J Mol Sci. 2018;19(3):765. Published 2018 Mar 7. doi:10.3390/ijms19030765
  191. Moe OW. Kidney stones: pathophysiology and medical management. Lan- cet. 2006;367(9507):333-344. doi:10.1016/S0140-6736(06)68071-9
  192. Johnson CM, Wilson DM, O'Fallon WM, Malek RS, Kurland LT. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int. 1979;16(5):624-631. doi:10.1038/ki.1979.173
  193. Romero V, Akpinar H, Assimos DG. Kidney stones: a global pic- ture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2-3):e86-e96.
  194. Yasui T, Okada A, Hamamoto S, et al. Pathophysiology-based treatment of urolithiasis. Int J Urol. 2017;24(1):32-38. doi:10.1111/iju.13187
  195. Huang WY, Chen YF, Carter S, Chang HC, Lan CF, Huang KH. Epide- miology of upper urinary tract stone disease in a Taiwanese population: a nationwide, population based study. J Urol. 2013;189(6):2158-2163. doi:10.1016/j.juro.2012.12.105
  196. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63(5):1817-1823. doi:10.1046/j.1523- 1755.2003.00917.x
  197. Kittanamongkolchai W, Vaughan LE, Enders FT, et al. The Changing In- cidence and Presentation of Urinary Stones Over 3 Decades. Mayo Clin Proc. 2018;93(3):291-299. doi:10.1016/j.mayocp.2017.11.018
  198. Nevo A, Golomb D, Lifshitz D, Yahav D. Predicting the risk of sepsis and causative organisms following urinary stones removal using uri- nary versus stone and stent cultures. Eur J Clin Microbiol Infect Dis. 2019;38(7):1313-1318. doi:10.1007/s10096-019-03555-6
  199. Sampathkumar P. Reducing catheter-associated urinary tract infections in the ICU. Curr Opin Crit Care. 2017;23(5):372-377. doi:10.1097/ MCC.0000000000000441
  200. Leone M, Garnier F, Avidan M, Martin C. Catheter-associated urinary tract infections in intensive care units. Microbes Infect. 2004;6(11):1026- 1032. doi:10.1016/j.micinf.2004.05.016
  201. Rosser CJ, Bare RL, Meredith JW. Urinary tract infections in the criti- cally ill patient with a urinary catheter. Am J Surg. 1999;177(4):287-290. doi:10.1016/s0002-9610(99)00048-3
  202. Cortes-Penfield NW, Trautner BW, Jump RLP. Urinary Tract Infection and Asymptomatic Bacteriuria in Older Adults. Infect Dis Clin North Am. 2017;31(4):673-688. doi:10.1016/j.idc.2017.07.002
  203. Kaye KS, Marchaim D, Chen TY, et al. Effect of nosocomial bloodstream infections on mortality, length of stay, and hospital costs in older adults. J Am Geriatr Soc. 2014;62(2):306-311. doi:10.1111/jgs.12634
  204. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287
  205. Nielsson MS, Christiansen CF, Johansen MB, Rasmussen BS, Tønnesen E, Nørgaard M. Mortality in elderly ICU patients: a cohort study. Acta Anaesthesiol Scand. 2014;58(1):19-26. doi:10.1111/aas.12211
  206. Pirracchio R, Petersen ML, Carone M, Rigon MR, Chevret S, van der Laan MJ. Mortality prediction in intensive care units with the Super ICU Learner Algorithm (SICULA): a population-based study. Lancet Respir Med. 2015;3(1):42-52. doi:10.1016/S2213-2600(14)70239-5
  207. Akinci M, Esen T, Tellaloğlu S. Urinary stone disease in Turkey: an updated epidemiological study. Eur Urol. 1991;20(3):200-203. doi:10.1159/000471700
  208. Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160-165. doi:10.1016/j.eururo.2012.03.052
  209. Cone EB, Hammill BG, Routh JC, et al. Disproportionate Use of Inpa- tient Care by Older Adults With Kidney Stones. Urology. 2018;120:103- 108. doi:10.1016/j.urology.2018.06.007
  210. Lieske JC, Peña de la Vega LS, Slezak JM, et al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006;69(4):760-764. doi:10.1038/sj.ki.5000150
  211. Bae SR, Seong JM, Kim LY, et al. The epidemiology of reno-ureteral stone disease in Koreans: a nationwide population-based study. Urolithiasis. 2014;42(2):109-114. doi:10.1007/s00240-014-0643-6
  212. Hugosson J, Grenabo L, Hedelin H, Lincolon K, Pettersson S. Chron- ic urinary tract infection and renal stones. Scand J Urol Nephrol. 1989;23(1):61-66. doi:10.1080/00365599.1989.11690432
  213. Omar M, Abdulwahab-Ahmed A, Chaparala H, Monga M. Does Stone Removal Help Patients With Recurrent Urinary Tract Infections? J Urol. 2015;194(4):997-1001. doi:10.1016/j.juro.2015.04.096
  214. Gravel D, Taylor G, Ofner M, et al. Point prevalence survey for healthcare- associated infections within Canadian adult acute-care hospitals. J Hosp Infect. 2007;66(3):243-248. doi:10.1016/j.jhin.2007.04.008
  215. Vincitorio D, Barbadoro P, Pennacchietti L, et al. Risk factors for catheter- associated urinary tract infection in Italian elderly. Am J Infect Control. 2014;42(8):898-901. doi:10.1016/j.ajic.2014.05.006
  216. Thomas B, Tolley D. Concurrent urinary tract infection and stone dis- ease: pathogenesis, diagnosis and management. Nat Clin Pract Urol. 2008;5(12):668-675. doi:10.1038/ncpuro1254
  217. Jan H, Akbar I, Kamran H, Khan J. Frequency of renal stone disease in patients with urinary tract infection. J Ayub Med Coll Abbottabad. 2008;20(1):60-62.
  218. Tavichakorntrakool R, Prasongwattana V, Sungkeeree S, et al. Exten- sive characterizations of bacteria isolated from catheterized urine and stone matrices in patients with nephrolithiasis. Nephrol Dial Transplant. 2012;27(11):4125-4130. doi:10.1093/ndt/gfs057
  219. Chant C, Smith OM, Marshall JC, Friedrich JO. Relationship of cathe- ter-associated urinary tract infection to mortality and length of stay in critically ill patients: a systematic review and meta-analysis of observa- tional studies. Crit Care Med. 2011;39(5):1167-1173. doi:10.1097/ CCM.0b013e31820a8581
  220. Canavan C, West J, and Card T. The epidemiology of irritable bowel syn- drome. Clin Epidemiol. 2014; 6:71-80.
  221. El-Serag HB. Impact of irritable bowel syndrome: prevalence and effect on health-related quality of life. Rev Gastroenterol Disord. 2003; 3 Suppl 2:S3-11.
  222. Huang WW, Zhou FS, Bushnell DM, Diakite C, Yang XH. Cultural ad- aptation and application of the IBS-QOL in China: a disease-specific quality-of-life questionnaire. Qual Life Res. 2007; 16:991-996.
  223. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected di- gestive diseases in the United States. Gastroenterology. 2002; 122:1500- 1511.
  224. Schuster MM. Diagnostic evaluation of the irritable bowel syndrome. Gastroenterol Clin North Am. 1991; 20:269-278.
  225. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012; 10:712-721.
  226. Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther. 2005; 21:1365-1375.
  227. Valenzuela J, Alvarado J, Cohen H, et al. Un consenso Latinoamericano sobre el síndrome de intestino irritable. Gastroenterol Hepatol. 2004; 27:325-343.
  228. Cash BD, Chey WD. Irritable bowel syndrome -an evidence-based ap- proach to diagnosis. Aliment Pharmacol Ther. 2004; 19:1235-1245.
  229. Nam SY, Kim BC, Ryu KH, Park BJ. Prevalence and Risk Factors of Ir- ritable Bowel Syndrome in Healthy Screenee Undergoing Colonoscopy and Laboratory Tests. Neurogastroenterol Motil. 2010; 16:47-51.
  230. Cremonini F, Camilleri M, Zinsmeister AR, Herrick LM, Beebe T, Talley NJ. Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil. 2009; 21:128-135.
  231. Rotem AY, Sperber AD, Krugliak P, Freidman B, Tal A, Tarasiuk A. Poly- somnographic and actigraphic evidence of sleep fragmentation in patients with irritable bowel syndrome. Sleep. 2003; 26:747-752.
  232. Nojkov B, Rubenstein JH, Chey WD, Hoogerwerf WA. The impact of ro- tating shift work on the prevalence of irritable bowel syndrome in nurses. Am J Gastroenterol. 2010; 105:842-847.
  233. Qureshi SR, Abdelaal AM, Janjua ZA, et al. Irritable Bowel Syndrome: A Global Challenge Among Medical Students. Cureus. Aug 2016; 8:e721. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC5010380/. Accessed Jan 2019.
  234. Ibrahim NKR, Battarjee WF, Almehmadi SA. Prevalence and predic- tors of irritable bowel syndrome among medical students and interns in King Abdulaziz University, Jeddah. Libyan J Med [Online]. Sep 2013;8: 21287. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3779356/. Accessed Jan 2019.
  235. Naeem SS, Siddiqui EU, Kazi AN, Memon AA, Khan ST, Ahmed B. Preva- lence and factors associated with irritable bowel syndrome among medi- cal students of Karachi, Pakistan: A cross-sectional study. BMC Res Notes [Online]. May 2012; 5: 255. Available from: https://www.ncbi.nlm.nih. gov/pmc/articles/PMC3434121/. Accessed Jan 2019.
  236. Liu Y, Liu L, Yang Y, et al. A School-Based Study of Irritable Bowel Syn- drome in Medical Students in Beijing, China: Prevalence and Some Re- lated Factors. Gastroenterol Res Prac [Online]. Oct 2014; 2014:124261. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC4211179/.
  237. Accessed Jan 2019.
  238. Wells M, Roth L, McWilliam M, Thompson K, Chande N. A cross-sec- tional study of the association between overnight call and irritable bowel syndrome in medical students. Can J Gastroenterol. 2012;26: 281-284.
  239. Lesage FX, Berjot S. Validity of occupational stress assessment using a visual analogue scale. Occup Med (Lond). 2011; 61:434-436.
  240. Ersryd A, Posserud I, Abrahamsson H, Simrén M. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III. Aliment Pharmacol Ther. 2007; 26:953-961.
  241. Bautista R, Ortiz RM, Muñoz S. Síndrome de intestino irritable en es- tudiantes de medicina. Rev Fac Med Univ Nac Auton Mex [Online]. Jun 2011; 54: 4-11. Available from: http://www.scielo.org.mx/scielo. php?script=sci_arttext&pid=S002617422011000300002&lng=es. Ac- cessed Jan 2019.
  242. Veitia G, Pernalete B, Cachima L, et al. Prevalencia del síndrome intestino irritable en la población adulta venezolana. Gen [Online]. Sep 2013;67: 139-144. Available from: http://www.genrevista.org/index.php/GEN/ article/view/147/pdf. Accessed Jan 2019.
  243. Kang JY. Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther. 2005; 21:663-676.
  244. Locke GR, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ. Familial as- sociation in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000; 75:907-912.
  245. Kalantar JS, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ. Is irritable bowel syndrome more likely to be persistent in those with relatives who suffer from gastrointestinal symptoms? A population-based study at three time points. Aliment Pharmacol Ther. 2003; 17:1389-1397.
  246. Levy RL, Jones KR, Whitehead WE, Feld SI, Talley NJ, Corey LA. Irrita- ble bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology. 2001; 121:799-804.
  247. Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: pathophysi- ology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol. 2011; 62:591-599.
  248. Popa SL, Dmitrascu D. Anxiety and IBS revisited: ten years later. Clujul Med. 2015; 88:253-257.
  249. Anuradha R, Dutta R, Raja JD, Sivaprakasam P, Patil AB. Stress and Stressors among Medical Undergraduate Students: A Cross-sectional PRHSJ Vol. 40 No. 1 • March, 2021
  250. Ramírez & Torres et al Study in a Private Medical College in Tamil Nadu. Indian J Community Med. 2017; 42:222-225.
  251. Yusoff MS, Abdul Rahim AF, Yaacob MJ. Prevalence and sources of stress among Universiti Sains Malaysia medical students. Malays J Med Sci. 2010; 17:30-37.
  252. Sayuk GS, Wolf R, Chang L. Comparison of symptoms, health care utili- zation and treatment in diagnosed and undiagnosed individuals with diar- rhea predominant irritable bowel syndrome. Am J Gastroenterol. 2017; 112:892-899.
  253. Spiegel BM, Farid M, Esrailian E, Talley J, Chang L. Is irritable bowel syn- drome a diagnosis of exclusion?: A survey of primary care providers, gas- troenterologists, and IBS experts. Am J Gastroenterol. 2010; 105:848-858.
  254. Molinder H, Agréus L, Kjellström L, et al. How individuals with the ir- ritable bowel syndrome describe their own symptoms before formal diag- nosis. Ups J Med Sci. 2015;1 20:276-279.
  255. Menon V, SarkarS, Kumar S. A cross-sectional analysis of barriers to healthcare seeking among medical students across training period. J Men- tal Health Hum Behav. 2017; 22: 97-103.
  256. Roberts LW, Hardee JT, Franchini G, Stidley CA, Siegler M. Medical stu- dents as patients: a pilot study of their health care needs, practices, and concerns. Acad Med. 1996;71: 1225-1232.
  257. Fujiwara Y, Kubo M, Kohata Y, et al. Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome. Intern Med. 2011; 50:2443-2447.
  258. Thomas GA, Rhodes J, Ingram JR. Mechanisms of disease: nicotine-a re- view of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol. 2005; 2:536-544
  259. Locke GR, Zinsmeister AR, Talley NJ, Fett SL, Melton LJ. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol; 2000; 95: 157-165.
  260. Nichter M, Nichter M, Carkoglu A, et al. Reconsidering stress and smok- ing: a qualitative study among college students. Tob Control. 2007; 16:211-214.
  261. Choi D, Ota S, Watanuki S. Does cigarette smoking relieve stress? Evi- dence from the event-related potential (ERP). Int J Psychophysiol. 2015; 98: 470-476.
  262. N = Number of children by age, n = Number of obese children by age and gender, 95% CI = 95% confidence interval of percent weighted prevalence, *p = 0.00009; chi-square test for obesity and age, **p = 0.0001; chi-square test for obesity and gender;
  263. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev. 2007;29:1-5. doi:10.1093/epirev/mxm012
  264. Obesity and overweight. World Health Organization. February 16, 2018. Accessed October 13, 2019. http://www.who.int/mediacentre/fact- sheets/fs311/en/
  265. Sorof JM, Lai D, Turner J, Poffenbarger T, Portman RJ. Overweight, eth- nicity, and the prevalence of hypertension in school-aged children. Pedi- atrics. 2004;113(3 Pt 1):475-482. doi:10.1542/peds.113.3.475
  266. Disdier-Flores OM, Jara-Castro AG. Anuario estadístico del sistema edu- cativo año escolar 2014-2015. Instituto de Estadísticas de Puerto Rico. 2017. Accessed October 18, 2018 https://estadisticas.pr/files/Publica- ciones/Anuario_Estadistico_Educativo_2014-2015.pdf PRHSJ Vol. 40 No. 1 • March, 2021
  267. Santiago et al
  268. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pres- sure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circula- tion. 2005;111(5):697-716. doi:10.1161/01.CIR.0000154900.76284.F6
  269. Corrado C. Blood pressure measurement in children. Ital J Pediatr. 2015;41(Suppl 2):A19. Published 2015 Sep 30. doi:10.1186/1824- 7288-41-S2-A19
  270. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11. 2002;(246):1-190.
  271. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555-576.
  272. EBMcalc. Foundation Internet Services; 2019.
  273. Bethlehem J. Applied survey methods -A statistical perspective: weight- ing. Wiley; 2009. Accessed October 10, 2019. http://www.applied-sur- vey-methods.com/weight.html#weg1
  274. QuickCalcs: Confidence interval of a proportion or count. GraphPad. 2019. Accessed October 10, 2019. https://www.graphpad.com/quick- calcs/Conf Interval1.cfm
  275. Statistical tutorials and software guides. Laerd Statistics. 2019. Accessed October 10, 2019. https://statistics.laerd.com
  276. Gignac GE. Non-Parametrics. In: How2statsbook (Online Edition 1). 2019. Accessed October 1, 2019. http://www.how2statsbook.com
  277. Lang TA, Secic M. How to Report Statistics in Medicine. American Col- lege of Physicians; 2006.
  278. IBM. SPSS. Version 25. International Business Machines. https://www. ibm.com/support/knowledgecenter/SSLVMB_25.0.0/statistics_kc_ ddita/spss/product_landing.html
  279. Venegas HL, Pérez CM, Suárez EL, Guzmán M. Prevalence of obesity and its association with blood pressure, serum lipids and selected lifestyles in a Puerto Rican population of adolescents 12-16 years of age [published correction appears in P R Health Sci J. 2003 Dec;22(4):417].
  280. P R Health Sci J. 2003;22(2):137-143.
  281. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of Obesity Among Adults and Youth: United States, 2015-2016. NCHS Data Brief. 2017;(288):1-8. Accessed October 9, 2019. https://www.cdc.gov/nchs/ data/databriefs/db288.pdf
  282. Ogden CL, Carroll MD, Lawman HG, et al. Trends in Obesity Preva- lence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014. JAMA. 2016;315(21):2292-2299. doi:10.1001/ jama.2016.6361
  283. Overweight children and youth. 2018. November 4, 2018. Child Trends. Accessed October 10, 2019. https://www.childtrends.org/indicators/ overweight-children-and-youth.
  284. Rosner B, Cook N, Portman R, Daniels S, Falkner B. Blood pressure dif- ferences by ethnic group among United States children and adolescents. Hypertension. 2009;54(3):502-508. doi:10.1161/HYPERTENSIO- NAHA.109.134049
  285. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. Summary Report. National Heart, Blood and Lung Institute. October 2012. Accessed October 8, 2019. https://www.nhlbi.nih.gov/files/docs/peds_guidelines_sum.pdf
  286. Irizarry-Alvarez F. Educación tendrá 41,000 estudiantes menos para este año escolar. Primera Hora. July 19, 2018. Accessed October 2, 2018. Available at: Url: http://www.primerahora.com/noticias/puerto-rico/ nota/educaciontendra41000estudiantesmenosparaesteanoescolaryc- uidaosimas-1293421/
  287. Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352(11):1138-1145. doi:10.1056/NEJMsr043743
  288. Primate Factsheet (http://pin.primate.wisc.edu/factsheets/entry/rhe- sus-macaque).
  289. Marriott, B, Roemer,J, Saltana C. An overview of the food intake patterns of the Cayo Santiago rhesus monkeys (Macaca mulatta): Report of a pilot study. PRHSJ 1989; 8:87-94.
  290. Preston, AM, Rodriguez-Orengo j, Gonzalez-Sepulveda, L. Aya- la-Pena, S Maldonado-Maldonado E. Effect of housing type on 25 OH vitamin D in serum of rhesus monkeys. PRHSJ 2018; 37:124-127.
  291. Hinde, K, Power, ML, Offedat, OT. Rhesus macaque milk: Magnitude, sources, and consequences of individual variation over lacation. Am J Phys Anthropol 2009; 138:148-157.
  292. Streym,vid S, Hojskov, CS, Moller, UK, Heickendorff, L, et al. Vitamin D content in human breast milk: a 9-mo follow-up study. Amer J Clin Nutr 2016; 103:107-114.
  293. Basile LA, Taylor SN, Wagner CL, Horst R, Hollis BW. The effect of high dose vitamin D supplements on serum vitamin D levels and milk calci- um concentrations in lactating women and their infants. Breastfed Med 2006;1:27-35.
  294. Dawodu, A, Tsang, RC. Maternal vitamin D status: Effect milk vita- min D content and Vitamin D status of breastfeeding infants. Adv Nutr 2012;3:353-361.
  295. Charrondiere UR, Haytowitz, D, Stadlmayr, B. FAO/Infoods density da- tabase. 2012; version 2.0.
  296. Preston, AM, Rodriguez Orango , J, Armstrong, R, Gonzalez Sepulveda, L Maldonado Maldonado, E, Rodriguez. IV. Effect of season on 25 (OH) vitamin D in serum of rhesus monkeys housed in Puerto Rico. PRHSJ 2018;37:143-147.
  297. Hoogenboezem, T, Degenhart, HJ, DeMuinck, SM, Keizer-Schrama, PF, Bouillon, R, et al. Vitamin D metabolism in breast-fed infants and their mothers. Ped Res 1989; 25:623-628.
  298. Chandrasekharan PK, Rawat M, Madappa R, Rothstein DH, Lakshmin- rusimha S. Congenital Diaphragmatic Hernia -a review. Matern Health Neonatol Perinatol. 2017;3:6. doi:10.1186/s40748-017-0045-1
  299. Sweed Y, Puri P. Congenital diaphragmatic hernia: influence of associated malformations on survival. Arch Dis Child. 1993;69(1 Spec No):68-70. doi:10.1136/adc.69.1_spec_no.68
  300. Lava JR, Hettwer GA, Reginatto CJ, et al. Congenital diaphragmatic Bochdaleck hernia: case report. Int Arch Med. 2012;5(1):30. Published 2012 Oct 30. doi:10.1186/1755-7682-5-30
  301. Kumar VH. Current Concepts in the Management of Congenital Dia- phragmatic Hernia in Infants. Indian J Surg. 2015;77(4):313-321. doi:10.1007/s12262-015-1286-8
  302. Woodward PJ, Kennedy A, Sohaey R, et al. In: Diagnostic imaging: Ob- stetrics. 1st ed. Amirsys; 2005:8-11.
  303. Daniilidis A, Balaouras D, Psarra N, et al. Increased nuchal translucency and diaphragmatic hernia. A case report. Clin Exp Obstet Gynecol. 2015;42(2):237-239.
  304. Sebire NJ, Snijders RJ, Davenport M, Greenough A, Nicolaides KH. Fetal nuchal translucency thickness at 10-14 weeks' gestation and con- genital diaphragmatic hernia. Obstet Gynecol. 1997;90(6):943-946. doi:10.1016/s0029-78844(97)89686-x
  305. Gerson LB, Fidler JL, Cave DR, Leighton JA. ACG Clinical Guideline: Diagnosis and Management of Small Bowel Bleeding. Am J Gastroen- terol. 2015;110(9):1265-1288. doi:10.1038/ajg.2015.246
  306. Sakai E, Ohata K, Nakajima A, Matsuhashi N. Diagnosis and therapeu- tic strategies for small bowel vascular lesions. World J Gastroenterol. 2019;25(22):2720-2733. doi:10.3748/wjg.v25.i22.2720
  307. Leung WK, Ho SS, Suen BY, et al. Capsule endoscopy or angiography in patients with acute overt obscure gastrointestinal bleeding: a prospec- tive randomized study with long-term follow-up. Am J Gastroenterol. 2012;107(9):1370-1376. doi:10.1038/ajg.2012.212
  308. Almeida N, Figueiredo P, Lopes S, et al. Urgent capsule endoscopy is useful in severe obscure-overt gastrointestinal bleeding. Dig Endosc. 2009;21(2):87-92. doi:10.1111/j.1443-1661.2009.00838.x
  309. Morowitz MJ, Markowitz R, Kamath BM, von Allmen D. Dieulafoy's le- sion and segmental dilatation of the small bowel: an uncommon cause of gastrointestinal bleeding. J Pediatr Surg. 2004;39(11):1726-1728. doi:10.1016/j.jpedsurg.2004.07.027
  310. Dulic-Lakovic E, Dulic M, Hubner D, et al. Bleeding Dieulafoy lesions of the small bowel: a systematic study on the epidemiology and efficacy of enteroscopic treatment. Gastrointest Endosc. 2011;74(3):573-580. doi:10.1016/j.gie.2011.05.027
  311. Kasapidis P, Georgopoulos P, Delis V, Balatsos V, Konstantinidis A, Skan- dalis N. Endoscopic management and long-term follow-up of Dieulafoy's lesions in the upper GI tract. Gastrointest Endosc. 2002;55(4):527-531. doi:10.1067/mge.2002.122652
  312. Ciobanu L, Pascu O, Diaconu B, Matei D, Pojoga C, Tanţău M. Bleeding Dieulafoy's-like lesions of the gut identified by capsule endoscopy. World J Gastroenterol. 2013;19(29):4823-4826. doi:10.3748/wjg.v19.i29.4823
  313. Abd Elrazek AE, Yoko N, Hiroki M, et al. Endoscopic management of Dieulafoy's lesion using Isoamyl-2-cyanoacrylate. World J Gastrointest Endosc. 2013;5(8):417-419. doi:10.4253/wjge.v5.i8.417
  314. Ding YJ, Zhao L, Liu J, Luo HS. Clinical and endoscopic analysis of gastric Dieulafoy's lesion. World J Gastroenterol. 2010;16(5):631-635. doi:10.3748/wjg.v16.i5.631
  315. Jamanca-Poma Y, Velasco-Guardado A, Piñero-Pérez C, et al. Prognostic factors for recurrence of gastrointestinal bleeding due to Dieulafoy's le- sion.
  316. World J Gastroenterol. 2012;18(40):5734-5738. doi:10.3748/wjg.

Related papers

2010 Situation Analysis: Elimination of MothertoChild Transmission of HIV and Congenital Syphilis in the Americas
Arachu Castro
View PDFchevron_right
Cuba Validated as the First Country to Eliminate Mother-to-Child Transmission of Human Immunodeficiency Virus and Congenital Syphilis: Lessons Learned from the Implementation of the Global Validation Methodology
Chika HAYASHI

Sexually Transmitted Diseases, 2016

View PDFchevron_right
• Special article on HealtH ScienceS reSearcH in puerto rico • Sexually transmitted infections clinics as Strategic Venues for targeting High risk pfor HiV research and Sexual Health interventions
Carlos E Rodriguez-Diaz

2011

puerto rico has one of the highest incidence rates of HiV in the u.S. concurrent with increases in sexually transmitted infections (Sti), an increasing share of the new infections in pr are associated with sexual transmission. Much of the available research on sexual risk in pr derives from Sti/HiV surveillance data. there is limited social and epidemiological research on sexual risk in pr, particularly in hidden and often hardto-reach populations at high risk. Despite the absence of substantial resources that most epidemiological studies require, a research collaboration was initiated in 2007 between researchers in the School of public Health at the university of puerto rico and the centro latinoamericano de enfermedades de transmisión Sexual (cletS), one of the largest publicly funded centers for Sti/HiV screening and treatment in the San Juan metropolitan area. Structured as a case study in the development of communitybased research collaborations, this paper describes the early history and development of the project, including formative research, recruitment and training of students, and evolution in the study design that contributed to the current configuration of the ongoing "core" study. preliminary data are presented, highlighting data from a number of subpopulations that may contribute to our understanding of the role of behavioral risk in the Sti/HiV epidemics in pr. More generally, the paper may guide the development of similar collaboration elsewhere in the caribbean where HiV risk is increasing but where resources for research in high risk settings and groups are scarce. [

View PDFchevron_right
The shape of the HIV/AIDS epidemic in Puerto Rico
Robert Hunter

Revista Panamericana de Salud Pública, 2000

This study presents information on AIDS patients in Puerto Rico, including their general sociodemographic profile, some risk-related parameters, characteristics of vulnerable groups, and elements of the clinical spectrum of the disease. Data were analyzed from the Puerto Rico AIDS Surveillance Program and available studies about the HIV/AIDS epidemic in Puerto Rico. A total of 23 089 AIDS cases was reported to the Puerto Rico AIDS Surveillance Program from January 1981 through February 1999. The HIV/AIDS epidemic has affected mostly males and females between the ages of 30 and 49, though cases have also been reported for other age groups. The cumulative proportion of persons with AIDS who are women has increased tremendously, from 11.4% for the 1981-1986 period to 21.6% for the entire 1981-1999 period. In Puerto Rico the category of injecting drug users (IDUs) accounts for the majority of the AIDS cases (52%), followed by heterosexual contact (22%), and men who have sex with men (17%). The three main diagnoses for AIDS on the island are wasting syndrome (30.7%); esophageal, bronchial, and lung candidiasis (29.4%); and Pneumocystis carinii pneumonia (26.8%). According to 1994 vital statistics for Puerto Rico, AIDS was the fourth-leading cause of death. The overall reported AIDS mortality rate was 42.0 per 100 000 persons, with the rate for males, 67.8, much higher than it was for females, 17.4. AIDS is the first cause of death among persons between 30 and 39 years old. Intense efforts are needed to better understand the epidemic in Puerto Rico and its biology, social and family impacts, and financial costs.

View PDFchevron_right
HIV and syphilis infection among men attending a [corrected] sexually transmitted infection clinic in Puerto Rico
Geetanjoli Banerjee

Puerto Rico health sciences journal, 2013

This study aimed to assess the demographic, behavioral, and clinical factors associated with HIV and syphilis infection among a sample of men attending a sexually transmitted infection clinic during 2009 to 2010 in San Juan, Puerto Rico (PR). A sample of 350 clinical records from men visiting the clinic for the first time during 2009 to 2010 was reviewed. Descriptive statistics were used to describe the study sample, and bivariate analyses were performed separately for HIV and syphilis to identify factors associated with these infectious diseases. Variables that were significantly associated (p &lt; 0.05) with HIV and syphilis in the bivariate analysis were considered for inclusion in the logistic regression models. Overall, 11.2% and 14.1% of the men were infected with HIV and syphilis, respectively, and 5.1% were coinfected with HIV and syphilis. In multivariate logistic regression models, ever injecting drugs (POR = 8.1; 95% CI 3.0, 21.8) and being a man who has sex with men (MSM...

View PDFchevron_right
580 California St., Suite 400
San Francisco, CA, 94104
© 2025 Academia. All rights reserved